BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 330 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 1.1%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $32,971,000 | +104.3% | 218,095 | +96.9% | 0.04% | +260.0% |
| Q2 2022 | $16,135,000 | +1317.8% | 110,743 | +1053.9% | 0.01% | +900.0% |
| Q1 2022 | $1,138,000 | -93.9% | 9,597 | -92.9% | 0.00% | -66.7% |
| Q4 2021 | $18,632,000 | +487.0% | 135,210 | +491.8% | 0.00% | +200.0% |
| Q3 2021 | $3,174,000 | +284.3% | 22,849 | +168.4% | 0.00% | – |
| Q2 2021 | $826,000 | -70.0% | 8,514 | -78.8% | 0.00% | -100.0% |
| Q1 2021 | $2,752,000 | -77.1% | 40,248 | -71.3% | 0.00% | -83.3% |
| Q4 2020 | $12,036,000 | +735.3% | 140,437 | +533.1% | 0.01% | +500.0% |
| Q3 2020 | $1,441,000 | -36.7% | 22,183 | -28.8% | 0.00% | -50.0% |
| Q2 2020 | $2,277,000 | -66.4% | 31,144 | -84.4% | 0.00% | -60.0% |
| Q1 2020 | $6,785,000 | -34.6% | 199,404 | +4.6% | 0.01% | -16.7% |
| Q4 2019 | $10,382,000 | +1191.3% | 190,693 | +889.0% | 0.01% | +500.0% |
| Q3 2019 | $804,000 | -76.4% | 19,281 | -75.2% | 0.00% | -66.7% |
| Q2 2019 | $3,402,000 | +0.9% | 77,672 | +18.5% | 0.00% | +50.0% |
| Q1 2019 | $3,373,000 | +28008.3% | 65,545 | +20192.6% | 0.00% | – |
| Q4 2018 | $12,000 | -97.6% | 323 | -97.5% | 0.00% | – |
| Q3 2018 | $492,000 | +8.8% | 13,107 | +14.5% | 0.00% | – |
| Q2 2018 | $452,000 | -93.9% | 11,446 | -96.0% | 0.00% | -100.0% |
| Q1 2018 | $7,431,000 | +8540.7% | 288,451 | +8962.2% | 0.01% | – |
| Q4 2017 | $86,000 | +59.3% | 3,183 | +120.7% | 0.00% | – |
| Q3 2017 | $54,000 | – | 1,442 | +17925.0% | 0.00% | – |
| Q2 2017 | $0 | – | 8 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 1,111,111 | $107,867,000 | 52.60% |
| Knoll Capital Management, LLC | 856,844 | $83,182,000 | 43.44% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,082,555 | $202,174,000 | 27.86% |
| ARS Investment Partners, LLC | 558,286 | $54,198,000 | 5.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $17,113,000 | 4.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 401,006 | $38,930,000 | 4.51% |
| Eventide Asset Management | 1,990,797 | $193,267,000 | 2.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 56,626 | $5,497,000 | 2.45% |
| Avidity Partners Management LP | 882,500 | $85,673,000 | 2.32% |
| Nicholas Investment Partners, LP | 363,708 | $35,309,000 | 2.22% |